PGT-M
Preimplantation Genetic Testing for Monogenic disorders

Prevent the transmission of single gene disorders in a family and achieve a healthy pregnancy

Scroll Down
 

Overview

  • For couples with a family history of monogenic diseases such as cystic fibrosis, fragile X syndrome, Huntington, etc.
  • It’s performed on the embryo before it is transferred to the uterus, as part of an assisted reproduction treatment.
  • Through analysis of the embryos, it is possible to select those that are free from the disorder.

 

Overview

Benefits

Image
Higher chance of a healthy baby

It maximises the chances of having a baby free from the disease for couples who have a high genetic risk.

Image
Possibility of PGT-M+PGT-A

 We can perform PGT-M and PGT-A for screening of aneuploidies in the same biopsy.

Image
We can perform PGT-M for most monogenic disorders
VIEW FULL LIST
Image
More than 300 diseases for which the PGT-M test is already developed

Methodology

PGTM
Technology

Technology

Igenomix uses state of the art technology for PGT-M.

  • Igenomix uses a multiple detection approach to ensure the most reliable results.
  • Using direct detection, PCR is used to detect the specific disease causing mutation.
  • Linkage analysis uses PCR to detect informative STR markers that are linked to the disease-causing gene.
  • Our multiple detection strategy minimizes the chances of no results or misdiagnosis due to allele drop out (ADO).
  • With our technology, our PGT-M testing is 98-99% accurate.

Our results

Our experts are professional, reliable and approachable and are available to help guide both professionals and patients throughout the entire process. We are proud to deliver high quality results for every test, every day.

300

DIFFERENT DISEASES

2,5 K

CYCLES

+20

YEARS' EXPERIENCE
IN GENETICS

98%

ACCURATE

Become our provider

Contact us now and we will guide you through the entire process

CONTACT US

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.